Market Cap 84.77M
Revenue (ttm) 119.48M
Net Income (ttm) -81.65M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -68.34%
Debt to Equity Ratio 1.01
Volume 143,800
Avg Vol 215,728
Day's Range N/A - N/A
Shares Out 18.80M
Stochastic %K 8%
Beta 1.96
Analysts Sell
Price Target $7.67

Company Profile

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing p...

Industry: Medical Devices
Sector: Healthcare
Phone: 669 231 8200
Address:
3052 Orchard Drive, San Jose, United States
SEACAI
SEACAI Aug. 18 at 11:05 AM
$OM 72% short volume yesterday. Someone was working overtime to push it down. And it did for a bit, but then recovered to close even. Interesting to see what happens in the next few days. But overall, it feels to be on the flip side, someone is accumulating.
0 · Reply
giu_ve
giu_ve Aug. 15 at 5:29 PM
$OM at 4$ everyone likes it. Then @ 5 the same sell. Rinse and repeat...
0 · Reply
Technicalcharter
Technicalcharter Aug. 14 at 3:44 PM
$OM it was given that we will get a bounce today. Charts screamed it. When I say this now doesn’t look good but I wanted to post before session started but forgot 🤣🤣. Happy Friday my fellow investors.
0 · Reply
ShangVXO
ShangVXO Aug. 14 at 1:27 PM
$OM probably gonna regret saying this but i like it
0 · Reply
giu_ve
giu_ve Aug. 11 at 9:06 PM
$OM shorts pile up when SP is above 5$. They usually win...
1 · Reply
giu_ve
giu_ve Aug. 10 at 6:48 PM
$OM 👁️👁️
0 · Reply
MikeyNJ
MikeyNJ Aug. 7 at 2:20 PM
$OM this remains a long term speculative play. It will be bid up when there is a clear inflection point. This earnings didn't do it.
1 · Reply
giu_ve
giu_ve Aug. 7 at 11:11 AM
$OM if SP goes south today, you can just call it manipulation
1 · Reply
SEACAI
SEACAI Aug. 6 at 9:17 PM
$OM overall, I like the outcome and the call. I still think they are too conservative (and the first question in Q&A tried to dislodge the conservatism, but to no avail). But fair enough, they upped the guidance at the Q2 ER last year only to post a mild reduction in capital sales in Q3 (which shifted to Q4) and the stock got hammered as an over reaction. Given the refresh and the elevated utilization that they mention and very high installation in Q2 (ie consummables revenue), I expect that they will exceed the targets for Q3 and then Q4 will come strong as it usually does. My only concern is in the potential delay of the full launch of Tablo 2.0 as they try to perfect the product (I am still hoping for early Q3 full launch).
1 · Reply
MikeyNJ
MikeyNJ Aug. 6 at 9:13 PM
$OM bottom line, the quarter was fine. They have adequate cash and remain optimistic that over time, they will execute the business plan to profitability. At less than one times revenue, the stock is cheap. The problem is that investors are impatient. This is a typical case where the CEO buying shares on the open market would do wonders for the stock price. Not holding my breath.
1 · Reply
Latest News on OM
Outset Medical Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Outset Medical Earnings Call Transcript: Q2 2026


Outset Medical Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Outset Medical Earnings release: Q2 2026


Outset Medical Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Outset Medical Quarterly report: Q2 2026


Outset Medical reports Q2 EPS (97c), consensus (72c)

2026-08-06T20:17:44.000Z - 12 days ago

Outset Medical reports Q2 EPS (97c), consensus (72c)


Outset Medical Reports Second Quarter 2026 Results

Aug 6, 2026, 4:01 PM EDT - 12 days ago

Outset Medical Reports Second Quarter 2026 Results


Osisko Intersects 80 Metres Averaging 1.93% Cu at Gaspé

Jun 9, 2026, 6:00 AM EDT - 2 months ago

Osisko Intersects 80 Metres Averaging 1.93% Cu at Gaspé


Outset Medical Transcript: AGM 2026

Jun 4, 2026, 4:30 PM EDT - 2 months ago

Outset Medical Transcript: AGM 2026


Outset Medical to Present at RBC Global Healthcare Conference

May 11, 2026, 4:05 PM EDT - 3 months ago

Outset Medical to Present at RBC Global Healthcare Conference


Outset Medical price target lowered to $10 from $12 at TD Cowen

2026-05-08T19:39:37.000Z - 3 months ago

Outset Medical price target lowered to $10 from $12 at TD Cowen


Outset Medical price target lowered to $6 from $8 at Stifel

2026-05-08T12:49:46.000Z - 3 months ago

Outset Medical price target lowered to $6 from $8 at Stifel


Outset Medical reports Q1 EPS ($1.03), consensus (79c)

2026-05-07T20:50:00.000Z - 3 months ago

Outset Medical reports Q1 EPS ($1.03), consensus (79c)


Outset Medical Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Outset Medical Earnings Call Transcript: Q1 2026


Outset Medical Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Outset Medical Earnings release: Q1 2026


Outset Medical Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Outset Medical Quarterly report: Q1 2026


Outset Medical Reports First-Quarter Results

May 7, 2026, 4:02 PM EDT - 3 months ago

Outset Medical Reports First-Quarter Results


Outset Medical Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Outset Medical Proxy statement: Proxy filing


Outset Medical Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 4 months ago

Outset Medical Proxy statement: Proxy filing


Outset Medical price target lowered to $12 from $15 at TD Cowen

2026-02-12T13:45:28.000Z - 6 months ago

Outset Medical price target lowered to $12 from $15 at TD Cowen


Outset Medical price target lowered to $15 from $17 at BTIG

2026-02-12T12:41:06.000Z - 6 months ago

Outset Medical price target lowered to $15 from $17 at BTIG


Outset Medical Earnings Call Transcript: Q4 2025

Feb 11, 2026, 4:30 PM EST - 6 months ago

Outset Medical Earnings Call Transcript: Q4 2025


Outset Medical Annual report: Q4 2025

Feb 11, 2026, 4:30 PM EST - 6 months ago

Outset Medical Annual report: Q4 2025


Outset Medical Earnings release: Q4 2025

Feb 11, 2026, 4:30 PM EST - 6 months ago

Outset Medical Earnings release: Q4 2025


Outset Medical reports Q4 EPS ($1.09), consensus (68c)

2026-02-11T21:11:53.000Z - 6 months ago

Outset Medical reports Q4 EPS ($1.09), consensus (68c)


Outset Medical reports Q4 revenue $28.9M, consensus $26.15M

2026-01-12T13:50:48.000Z - 7 months ago

Outset Medical reports Q4 revenue $28.9M, consensus $26.15M


Outset Medical appoints Prange to its board of directors

2026-01-12T13:50:24.000Z - 7 months ago

Outset Medical appoints Prange to its board of directors

ATRC


Outset Medical Reports Unaudited Fourth Quarter and 2025 Results

Jan 12, 2026, 8:30 AM EST - 7 months ago

Outset Medical Reports Unaudited Fourth Quarter and 2025 Results


Outset Medical Slides: Investor presentation

Jan 9, 2026, 7:00 AM EST - 7 months ago

Outset Medical Slides: Investor presentation


Outset Medical price target lowered to $8 from $14 at Stifel

2026-01-07T12:41:25.000Z - 8 months ago

Outset Medical price target lowered to $8 from $14 at Stifel


Outset Medical management to meet virtually with BTIG

2025-12-03T18:45:20.000Z - 9 months ago

Outset Medical management to meet virtually with BTIG


Outset Medical Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 10:40 AM EST - 9 months ago

Outset Medical Transcript: Stifel 2025 Healthcare Conference


Outset Medical price target lowered to $15 from $25 at TD Cowen

2025-11-11T12:55:20.000Z - 10 months ago

Outset Medical price target lowered to $15 from $25 at TD Cowen


Outset Medical price target lowered to $14 from $17 at Stifel

2025-11-11T12:45:14.000Z - 10 months ago

Outset Medical price target lowered to $14 from $17 at Stifel


Outset Medical price target lowered to $17 from $39 at BTIG

2025-11-11T12:20:36.000Z - 10 months ago

Outset Medical price target lowered to $17 from $39 at BTIG


Outset Medical Earnings Call Transcript: Q3 2025

Nov 10, 2025, 4:30 PM EST - 10 months ago

Outset Medical Earnings Call Transcript: Q3 2025


Outset Medical Quarterly report: Q3 2025

Nov 10, 2025, 4:30 PM EST - 10 months ago

Outset Medical Quarterly report: Q3 2025


Outset Medical Earnings release: Q3 2025

Nov 10, 2025, 4:30 PM EST - 10 months ago

Outset Medical Earnings release: Q3 2025


Outset Medical Reports Third-Quarter Results

Nov 10, 2025, 4:05 PM EST - 10 months ago

Outset Medical Reports Third-Quarter Results


Outset Medical Earnings Call Transcript: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Outset Medical Earnings Call Transcript: Q2 2025


Outset Medical Quarterly report: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Outset Medical Quarterly report: Q2 2025


Outset Medical Earnings release: Q2 2025

Aug 6, 2025, 5:00 PM EDT - 1 year ago

Outset Medical Earnings release: Q2 2025


Outset Medical Names First Chief Nursing Officer

Jul 30, 2025, 9:01 AM EDT - 1 year ago

Outset Medical Names First Chief Nursing Officer


Outset Medical Transcript: AGM 2025

Jun 2, 2025, 1:30 PM EDT - 1 year ago

Outset Medical Transcript: AGM 2025


Outset Medical Proxy statement: Proxy Filing

May 14, 2025, 8:00 AM EDT - 1 year ago

Outset Medical Proxy statement: Proxy Filing


Outset Medical Earnings Call Transcript: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Outset Medical Earnings Call Transcript: Q1 2025


Outset Medical Quarterly report: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Outset Medical Quarterly report: Q1 2025


Outset Medical Earnings release: Q1 2025

May 7, 2025, 5:00 PM EDT - 1 year ago

Outset Medical Earnings release: Q1 2025


Outset Medical Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Outset Medical Proxy statement: Proxy Filing


Outset Medical Proxy statement: Proxy Filing

Apr 11, 2025, 8:00 AM EDT - 1 year ago

Outset Medical Proxy statement: Proxy Filing


Outset Medical Announces One-for-Fifteen Reverse Stock Split

Mar 18, 2025, 8:30 AM EDT - 1 year ago

Outset Medical Announces One-for-Fifteen Reverse Stock Split


Outset Medical Registration statement: Registration Filing

Feb 26, 2025, 7:00 AM EST - 1 year ago

Outset Medical Registration statement: Registration Filing


Outset Medical Earnings Call Transcript: Q4 2024

Feb 19, 2025, 5:00 PM EST - 1 year ago

Outset Medical Earnings Call Transcript: Q4 2024


Outset Medical Annual report: Q4 2024

Feb 19, 2025, 5:00 PM EST - 1 year ago

Outset Medical Annual report: Q4 2024


Outset Medical Earnings release: Q4 2024

Feb 19, 2025, 5:00 PM EST - 1 year ago

Outset Medical Earnings release: Q4 2024


Outset Medical Announces Resolution of Warning Letter

Feb 13, 2025, 4:35 PM EST - 1 year ago

Outset Medical Announces Resolution of Warning Letter


Outset Medical Registration statement: Registration Filing

Feb 13, 2025, 7:00 AM EST - 1 year ago

Outset Medical Registration statement: Registration Filing


Outset Medical Proxy statement: Proxy Filing

Feb 4, 2025, 7:00 AM EST - 1 year ago

Outset Medical Proxy statement: Proxy Filing


Outset Medical Proxy statement: Proxy Filing

Jan 24, 2025, 7:00 AM EST - 1 year ago

Outset Medical Proxy statement: Proxy Filing


Outset Medical Slides: Investor Presentation

Jan 16, 2025, 7:00 AM EST - 1 year ago

Outset Medical Slides: Investor Presentation


Outset Medical Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 10:20 AM EST - 1 year ago

Outset Medical Transcript: Stifel 2024 Healthcare Conference


Outset Medical Earnings Call Transcript: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Outset Medical Earnings Call Transcript: Q3 2024


Outset Medical Quarterly report: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Outset Medical Quarterly report: Q3 2024


Outset Medical Earnings release: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Outset Medical Earnings release: Q3 2024


Outset Medical Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:02 PM EST - 1 year ago

Outset Medical Reports Third Quarter 2024 Financial Results


SEACAI
SEACAI Aug. 18 at 11:05 AM
$OM 72% short volume yesterday. Someone was working overtime to push it down. And it did for a bit, but then recovered to close even. Interesting to see what happens in the next few days. But overall, it feels to be on the flip side, someone is accumulating.
0 · Reply
giu_ve
giu_ve Aug. 15 at 5:29 PM
$OM at 4$ everyone likes it. Then @ 5 the same sell. Rinse and repeat...
0 · Reply
Technicalcharter
Technicalcharter Aug. 14 at 3:44 PM
$OM it was given that we will get a bounce today. Charts screamed it. When I say this now doesn’t look good but I wanted to post before session started but forgot 🤣🤣. Happy Friday my fellow investors.
0 · Reply
ShangVXO
ShangVXO Aug. 14 at 1:27 PM
$OM probably gonna regret saying this but i like it
0 · Reply
giu_ve
giu_ve Aug. 11 at 9:06 PM
$OM shorts pile up when SP is above 5$. They usually win...
1 · Reply
giu_ve
giu_ve Aug. 10 at 6:48 PM
$OM 👁️👁️
0 · Reply
MikeyNJ
MikeyNJ Aug. 7 at 2:20 PM
$OM this remains a long term speculative play. It will be bid up when there is a clear inflection point. This earnings didn't do it.
1 · Reply
giu_ve
giu_ve Aug. 7 at 11:11 AM
$OM if SP goes south today, you can just call it manipulation
1 · Reply
SEACAI
SEACAI Aug. 6 at 9:17 PM
$OM overall, I like the outcome and the call. I still think they are too conservative (and the first question in Q&A tried to dislodge the conservatism, but to no avail). But fair enough, they upped the guidance at the Q2 ER last year only to post a mild reduction in capital sales in Q3 (which shifted to Q4) and the stock got hammered as an over reaction. Given the refresh and the elevated utilization that they mention and very high installation in Q2 (ie consummables revenue), I expect that they will exceed the targets for Q3 and then Q4 will come strong as it usually does. My only concern is in the potential delay of the full launch of Tablo 2.0 as they try to perfect the product (I am still hoping for early Q3 full launch).
1 · Reply
MikeyNJ
MikeyNJ Aug. 6 at 9:13 PM
$OM bottom line, the quarter was fine. They have adequate cash and remain optimistic that over time, they will execute the business plan to profitability. At less than one times revenue, the stock is cheap. The problem is that investors are impatient. This is a typical case where the CEO buying shares on the open market would do wonders for the stock price. Not holding my breath.
1 · Reply
giu_ve
giu_ve Aug. 6 at 8:18 PM
$OM 31.6 millions better than 2nd quarter 2025 (31.4). I take it....
0 · Reply
Technicalcharter
Technicalcharter Aug. 6 at 8:14 PM
$OM keeping same guidance is not a good idea. They had to give something to cheer now it’s up to the call and how bullish they sound.
1 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 8:11 PM
$OM Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.97 up 6.73% YoY • Reported revenue of $31.64M up 0.69% YoY • Outset Medical reiterated its 2026 revenue guidance of $125 million to $130 million, representing a 5% to 9% increase over 2025, and expects non-GAAP gross margin in the low-40% to mid-40% range.
0 · Reply
ShaunmanO
ShaunmanO Aug. 5 at 11:06 PM
$CLOV Hopefully $OM will have a similar ER tomorrow. My second largest holding behind Clov.
0 · Reply
giu_ve
giu_ve Aug. 5 at 1:35 PM
$OM ER tomorrow. Will the MFs who have been manipulating SP for so long let SP above 5$ for 2/3 consecutive days. Shorts have covered half of the shares wrt previous month, good sign? Tomorrow night we shall know....
0 · Reply
Technicalcharter
Technicalcharter Aug. 4 at 4:08 PM
$OM this has been a long consolidation between 3 and 6.5; if everything goes well; this should go to 11.4 this month.
0 · Reply
MikeyNJ
MikeyNJ Aug. 4 at 1:45 PM
$OM They hinted about getting more clarity on the new contracts last call. If they can confidently now raise guidance, this should gap up significantly. We will see tomorrow.
1 · Reply
DrZingo
DrZingo Aug. 3 at 7:32 PM
0 · Reply
focafoca99
focafoca99 Jul. 29 at 4:34 PM
$OM cautions investors that a law firm is probing potential fiduciary breaches by its officers and directors.
0 · Reply
SEACAI
SEACAI Jul. 29 at 7:20 AM
$OM it wants to cross 5, and beyond before the ER. Let’s see. One thing is for sure, shorts are unwinding. This is very clear from the short interest percentage in the last month.
0 · Reply
giu_ve
giu_ve Jul. 28 at 4:00 PM
$OM let's claim back to 5$ before ER
0 · Reply
premarketmaker
premarketmaker Jul. 27 at 11:32 AM
$ELAB they are ruthless this morning - trusting nothing $KIDZ $PFSA $MTNB $OM
0 · Reply